INSPIRED: From left, Nicholas DaSilva, Benjamin Barlock and Kenneth Rose, Ph.D. students at the University of Rhode Island’s College of Pharmacy, discuss the drug-development company they launched, Alcinous Pharmaceuticals. / COURTESY URI/NORA LEWIS
Fed up with the “status quo” in the pharmaceutical industry and inspired by the “endless possibilities” in drug development, current University of Rhode Island College of Pharmacy Ph.D. students Kenneth Rose, Nicholas DaSilva and Benjamin Barlock launched Alcinous Pharmaceuticals last December. The human body “is one giant puzzle,” said Rose of the URI-based company’s challenge.…
You must be a paid subscriber to read this content.
To keep reading and receive unlimited access subscribe today for only $1.
Subscribe NowAlready a Subscriber?
Login now
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.
